Cargando…
Biomarkers of Metabolic (Dysfunction)-associated Fatty Liver Disease: An Update
The prevalence of metabolic (dysfunction)-associated fatty liver disease (MAFLD) is rapidly increasing and affects up to two billion individuals globally, and this has also resulted in increased risks for cirrhosis, hepatocellular carcinoma, and liver transplants. In addition, it has also been linke...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
XIA & HE Publishing Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845164/ https://www.ncbi.nlm.nih.gov/pubmed/35233382 http://dx.doi.org/10.14218/JCTH.2021.00248 |